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ABSTRACT
 Background and Purpose: Influenza is a considerable health problem all 
over the world. Vaccination is the most important measure for preventing 
influenza and reducing morbidity and mortality. The aims of this study were 
to assess influenza vaccination coverage from 2001 to 2007 in Germany, to 
understand motivations and barriers to vaccination, and to identify vaccina-
tion intentions for season 2007/08.
 Methods: In representative household surveys, 12,039 telephone interviews 
with individuals aged ≥ 14 years were conducted between 2001 and 2007. 
Essentially the same questionnaire was used in all seasons.
 Results: In season 2006/07, the overall influenza vaccination coverage 
rate dropped from 32.5% in the previous season to 27.4%. In the elderly 
(≥ 60 years), the rate decreased from 51.6% to 44.7% and the odds ratio of 
being vaccinated, compared to those not belonging to a high-risk group, 
remained < 5. Chronically ill elderly persons had an odds ratio of vaccination 
of 7, while younger chronically ill persons and health-care workers had odds 
ratios of about 2. Perceiving influenza as a serious illness was the most frequent 
reason for getting vaccinated. 14% of those vaccinated in 2006/07 indicated 
the threat of avian flu as a reason. The main reason for not getting vaccinated 
was thinking not to be likely to catch the flu. A recommendation by the fam-
ily doctor/nurse was perceived as the major encouraging factor for vaccination. 
A total of 44.7% of the respondents intended to get vaccinated against influ-
enza in 2007/08.
 Conclusion: A trend of increasing vaccination rates was observed from 
2001 to 2006 in Germany, but the rates dipped by almost a sixth after 2005/06. 
The loss of media interest in the threat of avian influenza after February 2006 
and stalling reimbursement programs may have contributed to the recent drop 
in vaccination rates.
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ZUSAMMENFASSUNG
Entwicklung der Influenzaimpfraten in Deutschland von 2001/02 bis 
2006/07
 Hintergrund und Ziel: Influenza stellt weltweit ein beachtliches Gesund-
heitsproblem dar. Die wirksamste Präventionsmaßnahme zur Senkung der 
There is ample evidence in the medical literature that influenza is 
a serious disease and that vaccination 
is efficacious and safe. Vaccination not 
only provides substantial health bene-
fits, it may also be associated with sig-
nificant economic benefits, not only 
among the elderly but also among 
healthy working adults and children. 
The German Standing Commission on 
Immunization (STIKO) currently rec-
ommends influenza vaccination for 
persons aged ≥ 60 years, persons with 
a chronic disease, persons with an in-
creased professional risk, and, only if a 
larger epidemic disease outbreak or a 
pandemic occurs, also for the general 
public [1]. Since mid 2007 the vaccina-
tion is reimbursed if recommended by 
the STIKO [2]. In spite of ongoing 
efforts by physicians, other health-care 
providers and policy makers, influenza 
vaccination coverage is barely sufficient 
to contain the enormous disease bur-
den.
The World Health Organization 
(WHO) and experts elsewhere main-
tain that the world is now closer to 
another influenza pandemic than at any 
time since the pandemic of 1968, the 
last of three in the previous century [3]. 
This situation underlines the impor-
tance of high immunization coverage 
rates in the general population, and 
particularly in subpopulations at high 
risk of influenza complications.
Previous publications based on 
cross-sectional data have reported in-
fluenza vaccination coverage rates for 
Germany [4–9]. Having available a 
consistent dataset for six consecutive 
seasons allows us to extend the usual 
cross-sectional approach to analyze 
vaccination rates.
This paper analyzes influenza vac-
cination coverage and related trends in 
Germany over six consecutive vaccina-
tion seasons, giving special attention to 
high-risk group coverage. Addition al 
objectives are to understand the causal 
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Mortalität und Morbidität ist die Schutzimpfung. Die Ziele der gegenwärtigen 
Untersuchung waren, die Influenzaimpfraten in Deutschland von 2001 bis 
2007 zu analysieren, eine Einsicht in Einflussfaktoren auf die Impfbereitschaft 
zu erhalten sowie die Impfabsicht für den folgenden Winter 2007/08 zu er-
fragen.
 Methodik: Zufallsgesteuerte Telefonumfragen wurden während der Jahre 
2001–2007 in 12 039 Haushalten durchgeführt. Die Stichprobengröße war 
repräsentativ für die nicht institutionalisierte deutsche Bevölkerung im Alter 
von ≥ 14 Jahren. Der verwendete Fragebogen war grundsätzlich in allen 
Jahren identisch.
 Ergebnisse: In der Grippesaison 2006/07 sank die Impfrate von 32,5% im 
vorherigen Jahr auf 27,4%. Bei den älteren Personen (≥ 60 Jahre) sank die 
Impfrate von 51,6% auf 44,7%. Personen ≥ 60 Jahre, welche chronisch krank 
waren, ließen sich weit häufiger impfen als jüngere chronisch Kranke oder 
die im Gesundheitswesen Tätigen. Der meistgenannte Beweggrund für eine 
Schutzimpfung war die Beurteilung, dass Influenza eine schwerwiegende 
Krankheit sei. 14% der geimpften Personen gaben als Grund die Furcht vor 
der Vogelgrippe an. Andererseits hielten es die meisten ungeimpften Personen 
für unwahrscheinlich, an Influenza zu erkranken. Eine Empfehlung vom 
Hausarzt oder durch Pflegepersonal war die stärkste Motivation für eine Imp-
fung. Im Hinblick auf die Grippesaison 2007/08 beabsichtigten 44,7% der 
Befragten, sich impfen zu lassen.
 Schlussfolgerung: Die Studie zeigt, dass sich trotz der gegenüber 2005/06 
um ein Sechstel gesunkenen Impfrate im Gesamtzeitraum von 2001 bis 2007 
eine steigende Tendenz der Impfteilnahme in Deutschland abzeichnet. Das 
nachlassende Medieninteresse an der Bedrohung durch die Vogelgrippe nach 
Februar 2006 sowie Verzögerungen bei Programmen für die Rückerstattung 
der Impfkosten haben möglicherweise dazu beigetragen, dass sich die Impf-
raten in Deutschland kurzfristig verringert haben.
Schlüsselwörter: Influenza · Impfung · Vogelgrippe · Population · Deutsch-
land · Trendkurven
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factors for being or not being vacci-
nated, to describe the motivations and 
barriers to vaccination, and to identify 
vaccination intentions for the season 
2007/08.
Methods
This survey is part of an ongoing in-
ternational assessment of influenza im-
munization uptake in Europe (France, 
Great Britain, Italy, Spain, Germany) 
[10]. During six influenza seasons, from 
2001/02 to 2006/07, a population-
based survey was conducted in Decem-
ber among German households, as part 
of an omnibus-type survey addressing 
different topics. Computer-assisted 
telephone interviews (CATI) were 
conducted by TNS healthcare (part of 
Taylor Nelson Sofres, London, UK) 
and the agreement of the interviewees 
was asked at the beginning of each call. 
There was no study intervention. Us-
ing quotas and weights based on data 
from official national sources assured 
that the reported sample of the survey 
(completed interviews) is representative 
of the noninstitutionalized German 
population aged ≥ 14 years in terms of 
gender, age, profession, region, and 
town size [8]. Four target groups based 
on national recommendations were 
specified [1, 11]:
(1) individuals aged ≥ 60 years;
(2) individuals who suffer from a 
chronic illness (e.g., chronic disea-
ses of respiratory organs, chronic 
cardiovascular or liver diseases, 
nephropathies, diabetes or other 
metabolic disorders, some forms of 
multiple sclerosis, congenital or 
acquired immune deficiencies);
(3) individuals who work in the med-
ical field;
(4) individuals belonging to one or 
more of the above groups 1, 2, and 
3 (composite target group).
Accordingly, the non-target group 
comprised individuals belonging to 
neither of groups 1, 2, and 3. The sur-
vey questionnaire has been published 
earlier [8]. From season 2005/06 on-
ward, questions on influenza pandem-
ics and avian influenza were added to 
the questionnaire.
To correct for small deviations from 
the age and gender quotas requested, 
sample weights were applied, and the 
annual datasets were pooled. SPSS® 
version 14 for Windows was used for 
the statistical evaluation. The χ2-test 
was used to assess bivariate associations 
of categorical variables, and the χ2-test 
for trends was used to assess time trends 
of categorical variables. Two-sided 
p ≤ 0.05 was set as the level of statisti-
cal significance for all statistical tests. 
95% confidence intervals (CI) were 
reported where appropriate. Due to the 
descriptive nature of this data, no cor-
rection for multiple testing was made. 
Expected predictor variables were con-
sidered candidates for multivariable 
analysis, and logistic regression was 
used to identify independent correlates 
of the outcome of interest, i.e., vac-
cination coverage. Potential predictors 
of vaccination were gender, age, 
chronic illness, working as health-care 
professional, income, and level of edu-
cation. The covariates were first in-
cluded in the 2006/07 model and re-
moved if not significant (p > 0.05). 
The regression models for all other 
seasons were based on the variables 
identified in season 2006/07.
Results
Demographic Data
For the 2006/07 coverage study, 
60,870 telephone contacts were made 
(inclu sive of busy signal or answering 
machine), resulting in 17,911 respons-
es, of which 2,007 persons completed 
the interview (11.2% of responses, 
3.3% of contacts) and 14,269 individu-
als refused.
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Since 2001 a total of 12,039 persons 
were interviewed. Table 1 gives an 
overview of the samples. The samples 
were composed similarly over the years 
and are representative of the population 
aged ≥ 14 years [8, 12].
Vaccination Coverage Rate
Influenza vaccination coverage dropped 
from 32.5% (95% CI 29.5%; 34.5%) in 
season 2005/06 to 27.4% (95% CI 
25.4%; 29.4%) in season 2006/07 (Fig-
ure 1). This drop was borderline sig-
nificant (p = 0.05). A drop similar in 
magnitude occurred from 26.8% (95% 
CI 24.8%; 28.8%) in season 2001/02 
to 22.2% (95% CI 20.2%; 24.2%) in 
season 2002/03, the lowest vaccination 
coverage measured in this series of sur-
veys. There was a steady increase there-
after to 26.4% (CI 24.4%; 28.4%) in 
season 2004/05, and a peak coverage 
rate of 32.5% (95% CI 29.5%; 34.5%) 
was reached in season 2005/06.
With respect to the coming winter 
of 2007/08, 44.7% of the interviewed 
intended to get vaccinated against in-
fluenza (Figure 1). Regarding season 
2006/07, 47.5% had expressed such an 
intention.
The proportion of vaccinated per-
sons who had also been vaccinated in 
the past decreased distinctly from 28.9% 
(95% CI 26.9%; 30.9%) of the total 
sample in season 2005/06 to 25.6% 
(95% CI 26.7%; 27.5%) in season 
2006/07, but was still higher than in 
season 2004/05 (23.7%, 95 % CI 21.8%; 
25.6%). By contrast, the proportion of 
persons who had been vaccinated in the 
past, but not in this season, increased 
markedly from 19.7% (95% CI 17.9%; 
21.4%) of the total sample in season 
2005/06 to 27.5% (95% CI 25.5%; 
29.5%) in season 2006/07. The propor-
tion of first-time immunizations (1.7%, 
95% CI 1.2%; 2.2%) was only half that 
of the previous season, while the pro-
portion of those who have never been 
vaccinated decreased from 47.5% (95% 
CI 45.3%; 49.7%) to 44.9% (95% CI 
44.8%; 47.1%). The latter confirms a 
decreasing trend (p for trend across sea-
sons < 0.001).
Vaccination Coverage in Target Groups
Vaccination coverage among those 
aged ≥ 60 years increased in seasons 
2004/05 and 2005/06 (51.6%), just to 
fall back to 44.7% in 2006/07. In all 
Table 1. Overview of sample. CI: confidence interval.
2001/02 2002/03 2003/04 2004/05 2005/06 2006/07
Total respondents (n) 2,003 1,999 2,012 2,001 2,017 2,007
Mean age (years)
(95% CI)
46.6
(45.8; 47.4)
46.9
(46.1; 47.7)
46.8
(46.0; 47.6)
47.3
(46.5; 48.1)
47.5
(46.7; 48.4)
47.5
(46.8; 48.4)
Male (%)
(95% CI)
47.8
(47.3; 48.3)
47.8
(47.3; 48.3)
47.8
(47.3; 48.3)
47.9
(47.4; 48.4)
47.9
(47.4; 48.4)
48.1
(47.6; 48.6)
Age ≥ 60 years (%)
(95% CI)
28.8
(28.5; 29.1)
29.6
(29.3; 29.9)
29.6
(29.3; 29.9)
24.3
(24.0; 24.7)
30.7
(30.4; 31.0)
31.0
(30.7; 31.3)
Work in the medical field (%)
(95% CI)
  6.7
  (4.8; 8.7)
  6.4
  (4.5; 8.4)
  6.4
  (4.5; 8.5)
  7.2
  (5.3; 9.1)
  7.3
  (5.4; 9.2)
  8.5
  (6.6; 10.4)
Chronic illness (%)
(95% CI)
– – 23.3
(21.5; 25.1)
30.7
(22.6; 26.1)
22.7
(21.0; 24.5)
24.4
(22.3; 26.2)
Composite target group (%)
(95% CI)
– – 46.2
(45.8; 46.7)
47.4
(46.9; 47.9)
47.2
(46.7; 47.7)
48.8
(48.3; 49.3)
Season
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Figure 1. Vaccination rates and intended vaccination rates in Germany 2001–2007 (p-values 
for trend across seasons).
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seasons, vaccination coverage was sig-
nificantly higher than in the non-target 
group or in persons < 60 years of age 
(p < 0.001). A question exploring the 
prevalence of chronic illness was added 
to the questionnaire in 2003/04. Over 
the four observed seasons, significant-
ly higher vaccination coverage was seen 
among the chronically ill compared to 
the non-target group. However, in 
season 2006/07, the vaccination cover-
age among those with a chronic disease 
(26.2%) dropped to the level of season 
2004/05 after having peaked to 35.1% 
in the previous season. The vaccination 
coverage among health-care workers 
(23.0%) was only 1.5 times higher than 
in the non-target group (15.3%). The 
data indicate no trend in vaccination 
coverage among health-care workers 
or among the chronically ill over the 
last 4 years (Figure 2). In the compos-
ite target group, a significant increase 
in vaccination coverage was observed 
over the period from 2003/04 to 
2005/06 (p for trend < 0.001). How-
ever, as in the individual target groups, 
there was a significant decrease in vac-
cination coverage between 2005/06 
and 2006/07.
Influences on Vaccination Coverage
Vaccination coverage differences across 
age were distinct. Older age (≥ 60 
years) was associated with higher cov-
erage (Figure 3). Of those < 60 years 
of age, the group aged 50–59 years had 
the highest coverage, followed by the 
youngest group (14–19 years). The 
group aged 20–29 years had the lowest 
coverage. In season 2006/07 compared 
to the previous season, the uptake was 
lower in all age groups (Figure 3). The 
decrease in the 60–79 years old was 
greater than the previous increase, but 
in all other age groups, the 2006/07 
rates remained higher than in 2004/05. 
The relative decrease was least in the 
group aged ≥ 80 years.
A gender difference was only ob-
served in season 2004/05, when  women 
were moderately more likely than men 
to be vaccinated (unadjusted odds ratio 
[OR]: 1.3; CI 1.0; 1.5) Pooled data 
from the first five seasons showed a 
higher vaccination rate among house-
holds with few children, a low educa-
tional level, and low income [9]. Such 
differences were not present in season 
2006/07 where the corresponding ORs 
fell to almost unity. A decrease in vac-
cination rates was observed among all 
income groups, most notably in the 
middle-class group (income range, 
2,000–2,499 Euros) where the OR 
dropped to 0.7 (95% CI 0.5; 1.0), from 
1.6 (95% CI 1.1; 2.4) in the previous 
season.
Multivariate analysis of vaccination 
coverage took membership in one or 
several target groups (covering age), 
gender, educational level, and income 
into account. As only target group 
membership (being chronically ill, el-
derly, or a health-care worker) had a 
statistically significant effect in season 
2006/07, the other potential influ-
ences (some of which were affected by 
substantial numbers of missing values) 
were not included in the final logistic 
regression model (Table 2). Regression 
confirmed age ≥ 60 years to be a sig-
nificant predictor of vaccination (ad-
Season
≥ 60 years old (p = 0.003)
Chronic illness (p = 0.213)
Health-care worker (p = 0.903)
Not in target group (p = 0.003)
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Figure 2. Trend curves of actual vaccination rates in German high-risk target groups and in 
the non-target group 2003–2007 (p-values for trend across seasons).
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Figure 3. Vaccinated population by age groups in Germany 2001–2007 (p-values for trend 
across seasons).
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justed OR in 2006/07, compared to 
the non-target group: 4.5; ORs rang-
ing from 3.8 in season 2003/04 to 5.0 
in seasons 2004/05 and 2005/06). The 
respondents in the chronically ill target 
group, in season 2006/07, had an OR 
of 2.0, which was less than in the three 
previous seasons (OR range: 2.5–2.6). 
Being aged ≥ 60 years and chronical-
ly ill raised the OR considerably in 
all seasons, with maxima in seasons 
2004/05 and 2005/06 (14.0 and 10.7, 
respectively) and a decrease to 7.0 in 
season 2006/07 (comparable to season 
2003/04). Health-care workers’ ORs 
ranged between 1.6 and 2.0.
The composite target group (at least 
one of age ≥ 60 years, chronic illness, 
health-care worker) had an OR of vac-
cination of 3.6 (95% CI 2.9; 4.5), com-
pared to the non-target group in season 
2006/07. Previous results for the com-
posite target group ranged from 3.6 (CI 
2.9; 4.5) in season 2001/02 to 5.2 (CI 
4.2; 6.5) in season 2004/05.
Motivations and Barriers 
for Vaccination
Reasons for getting or not getting vac-
cinated are shown in Table 3. Those 
who indicated to have been vaccinated 
in the current season most frequently 
stated “because the flu is a serious ill-
ness and I did not want to get it” as a 
reason (season 2006/07: 90%, Table 3). 
In all seasons, this was the most fre-
quent reason for getting vaccinated, 
and set off distinctly from the lower-
ranking reasons. Second were the fol-
lowing two reasons: “my family doc-
tor/nurse advised me to do it” (71%) 
and “so that I do not pass the flu bug 
to my family and friends” (69%). These 
rankings were consistent over all sea-
sons. The attention on avian influenza 
and on influenza pandemics had influ-
enced the decision of 14% of the vac-
cinated. This subgroup was not statisti-
cally different from the other vacci-
nated in terms of age, gender, and 
target group membership. The propor-
tion of first-time vaccinated among 
those who indicated avian influenza as 
a reason for vaccination was 5.3%, con-
siderably less than in the previous sea-
son (19.3%).
In season 2006/07, the most com-
mon response from those never vacci-
nated before was, “I do not think I am 
very likely to catch the flu” (48%, Table 
3). Second in rank, with similar fre-
quency, was, “I thought about it but I 
did not end up getting vaccinated” 
(47%). These reasons were ranking first 
or second in all seasons. Responses “it 
is not a serious enough illness” (40%) 
and “my family doctor did not recom-
mend it to me” (39%) were ranking 
third and fourth in season 2006/07 and 
similarly in the previous seasons. Persons 
previously vaccinated but not in season 
2006/07, said that they did not feel con-
cerned (39%; previous season 46%), or 
that they did not think about getting 
vaccinated, respectively forgot (36%).
Table 2. Adjusted odds ratios of vaccination coverage in target groups. CI: confidence interval.
2003/04
(n = 2,004)ª
2004/05
(n = 1,988)ª
2005/06
(n = 2,008)ª
2006/07
(n = 1,996)ª
Age ≥ 60 yearsb 3.8 5.0 4.9 4.5
(95% CI) (2.9; 5.0) (3.8; 6.7) (3.8; 6.4) (3.4; 5.9)
p-value < 0.001 < 0.001 < 0.001 < 0.001
n 335 323 326 329
Chronic illnessb 2.5 2.6 2.5 2.0
(95% CI) (1.8; 3.5) (1.8; 3.7) (1.8; 3.5) (1.4; 2.8)
p-value < 0.001 < 0.001 < 0.001 < 0.001
n 201 191 191 190
Chronic illness and age ≥ 60 yearsb 6.5 14.0 10.7 7.0
(95% CI) (4.7; 8.9) (10.1; 19.2) (7.8; 14.7) (5.2; 9.5)
p-value < 0.001 < 0.001 < 0.001 < 0.001
n 194 207 194 208
Work in medical fieldb 1.9 2.0 1.6 1.7
(95% CI) (1.1; 3.1) (1.2; 3.3) (1.0; 2.5) (1.1; 2.6)
p-value 0.016 0.006 0.034 0.026
n 115 117 141 118
ª  n < total sample size for this season due to missing covariate values
b  reference category: non-target group (persons who do not belong to any target group)
Note: some persons worked in the medical field and were at the same time ≥ 60 years old and/or chronically ill. These persons were taken into account 
when the logistic regression model was estimated but group sizes were too small for reliable parameter estimates. Therefore, parameter estimates for 
these groups are not shown
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Knowledge about influenza vac-
cination in season 2006/07 (Table 4) 
was similar to previous seasons (data 
not shown), despite increased aware-
ness of pandemic risks in the population 
[13]. Three quarters of the surveyed 
knew that it is possible to catch influ-
enza even if vaccinated, and about two 
thirds knew that the infection is then 
less severe. One quarter of the respon-
dents agreed with the statement that 
the influenza vaccine would protect 
them against avian influenza, although 
the majority disagreed with this state-
ment (68%, Table 4).
The survey also revealed (Table 5) 
that
• a recommendation by the family 
doctor/nurse (rank 1 in all seasons, 
64–69%),
• knowing more about the efficacy and 
tolerability of the vaccine (rank 2 in 
all seasons, 54–56%),
• knowing more about the disease 
(rank 3 in all but the season 2001/02, 
47–54%),
• none or lower cost (rank 4 in all sea-
sons, 32–44%),
• vaccination offered at work (rank 5 
in four out of six seasons, 33–42%),
would encourage most people to get 
vaccinated.
DISCUSSION
Telephone interviews have been used 
on several occasions to study vaccina-
tion coverage in Germany [4, 5, 7–9, 
14]. The main advantage of telephone 
interviews is a potentially high response 
rate obtained in an affordable and fast 
manner. The selection process based 
on random drawing of telephone num-
bers has been shown to be of high qual-
ity [15]. The major potential reason for 
selection bias despite correct sampling 
is nonresponse. Comparisons of 
face-to-face, mailed and telephone sur-
veys addressing health-related issues, 
however, revealed only small differ-
ences between modes of administration 
and little nonresponse effects with re-
spect to prevalence estimates [12, 16]. 
Compared to mailed surveys, nonre-
sponse in telephone surveys was found 
to be less content-oriented [17]. More-
over, bias due to different sociodemo-
graphic characteristics of persons not 
reachable by telephone only slightly 
affected reports of illness and related 
use of medical services, provided the 
general population was addressed and 
telephone coverage was at least 90% 
[17, 18]. These published findings sup-
port the validity of our approach, al-
though we had no means of indepen-
dently confirming self-reported vac-
cination status. The limitations of the 
present data collection were also de-
scribed in greater detail in an earlier 
publication [8]. An increasing problem 
is the use of wireless telephones. It was 
shown in the USA that persons with 
landlines had a higher odds (1.27) of 
being vaccinated than those with only 
access to wireless telephones [19]. If 
the same holds true for Germany, 
where mobile phones are even more 
common than in the USA [20, 21], we 
may have slightly overestimated the 
vaccination rates.
In Germany, overall vaccination 
coverage decreased significantly in sea-
son 2006/07 compared to season 
Table 3. Ranking of reasons for and against vaccination.
Motivations for getting vaccinated 
(among those vaccinated)
2001/02
(n = 537)
Rank (%)
2002/03
(n = 443)
Rank (%)
2003/04
(n = 503)
Rank (%)
2004/05
(n = 528)
Rank (%)
2005/06
(n = 656)
Rank (%)
2006/07
(n = 549)
Rank (%)
Because the flu is a serious illness and I did not 
want to get it
1 (83) 1 (90) 1 (90) 1 (89) 1 (88) 1 (90)
My family doctor/nurse advised me to do it 2 (66) 2 (72) 3 (70) 2 (73) 2 (68) 2 (71)
So that I do not pass the flu bug to my family and 
friends
3 (62) 3 (70) 2 (71) 3 (71) 3 (67) 3 (69)
Because of my age 4 (47) 4 (40) 4 (40) 4 (45) 4 (38) 4 (39)
Because it’s free: the Social Security system pays 
for it
6 (21) 5 (36) 5 (34) 6 (26) 5 (37) 5 (46)
Reasons for not getting vaccinated 
(among those never vaccinated)
2001/02
(n = 1,017)
Rank (%)
2002/03
(n = 1,041)
Rank (%)
2003/04
(n = 1,036)
Rank (%)
2004/05
(n = 962)
Rank (%)
2005/06
(n = 959)
Rank (%)
2006/07
(n = 900)
Rank (%)
I do not think I am very likely to catch the flu 1 (38) 1 (47) 2 (41) 2 (41) 2 (44) 1 (48)
I thought about it but I did not end up getting 
vaccinated
– 2 (44) 1 (52) 1 (52) 1 (50) 2 (47)
It is not a serious enough illness 2 (33) 4 (37) 4 (35) 5 (32) 3 (34) 3 (40)
My family doctor did not recommend it to me 4 (30) 5 (37) 3 (36) 3 (36) 4 (33) 4 (39)
My pharmacist did not recommend it to me – 3 (38) 5 (32) 6 (32) 5 (31) 5 (33)
I have never considered it before 3 (30) 6 (31) 6 (31) 7 (32) 5 (31) 6 (31)
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2005/06, but was still higher than in 
the years before. This was true for all 
age groups with the exception of the 
60–79 old whose coverage fell to 
pre-2005/06 levels. It appears that a 
partial extension of reimbursement of 
influenza vaccination (introduction of 
full reimbursement of vaccination in 
all enrolees, by some insurance com-
panies), in effect since 2005 [22], was 
not successful in modulating longer-
term vaccination coverage to a relevant 
degree [9]. Vaccination target groups 
will be covered by the Statutory Health 
Insurance from 2007/08 on [2] and it 
remains to be seen whether this factor 
can reverse the observed decrease in 
coverage in the next season.
The German media have been par-
ticularly active in reporting on avian 
influenza and a possible shortage of 
antiviral agents in the years before sea-
son 2006/07. This apparently has in-
creased the population’s awareness of 
pandemic risks and, by consequence, 
positively influenced vaccination cov-
erage. The attention on pandemics and 
avian influenza may also have encour-
aged more doctors to recommend vac-
cination. After February 2006, how-
ever, media coverage, and thus public 
awareness, of avian influenza has dwin-
dled [13]. This is a possible cause of the 
coincident falling back of vaccination 
rates to pre-season-2005/06 levels.
Low frequency and severity of in-
fluenza during 2005 and 2006 could be 
another explanation for the lower fre-
quency of vaccine usage [23]. Never-
theless, the lower coverage cannot be 
attributed to the fact of a shortness of 
vaccine, as there was no significant 
change in doses distributed between 
seasons 2006/07 and the previous year 
(2005/06).
The overall vaccination rate in elev-
en European countries was 20.2% in 
season 2006/07 (unpublished data). 
Thus, the vaccination rate in Germany 
(27.4%) was above the European aver-
age, as in previous seasons [8, 24]. Our 
observations on immunization uptake 
in the German population are consis-
tent with findings from similar studies 
performed in Germany [5, 14, 25, 
26].
The elderly and those with a chron-
ic disease showed coverage rates above 
the average and are among the influ-
enza vaccination target groups defined 
by the STIKO [11], which is putativ ely 
the main reason for high coverage. 
However, working in the medical field 
in Germany did not markedly encour-
age vaccination, with the odds in this 
group never even doubling those in 
the non-target group. Earlier publica-
tions on influenza coverage rates [4, 9, 
26–29] already noted a low coverage 
in health-care workers in Germany, 
ranging from 8% [27] to 26% [26]. By 
comparison, we found a vaccination 
coverage range between 22% and 26% 
in the surveys from 2001/02 to 
2006/07, while the non-target group 
remained < 18%.
With respect to individual drivers 
of vaccination, our data confirm that 
the major encouraging factor is a rec-
ommendation from the family doctor 
or nurse. This finding was confirmed 
in other publications [4, 7–9, 14, 30]. 
A better understanding of the disease 
and the vaccine would have encour-
Table 4. Knowledge about influenza and vaccination (winter 2006/07, n = 2,007).
Agree (%) Disagree (%) Don’t know (%)
You can catch influenza even if you are vaccinated against it 75.7 20.4   3.9
If you catch influenza after having had the vaccine, the infection is less severe 66.1 26.2   7.7
The side effects associated with the vaccine (fever, headache, etc.) are acceptable 58.8 29.0 12.2
It is important to get the influenza vaccine each year 57.3 41.3   1.4
The influenza vaccine is not useful if you are in good health 42.5 54.4   3.1
If you have the vaccine you will not catch the flu 32.4 63.6   4.0
The influenza vaccine will protect me in case of avian influenza/influenza pandemic 27.5 67.8   4.7
Table 5. Encouragements for vaccination.
2001/02
(n = 2,003)
Rank (%)
2002/03
(n = 1,999)
Rank (%)
2003/04
(n = 2,012)
Rank (%)
2004/05
(n = 2,001)
Rank (%)
2005/06
(n = 2,017)
Rank (%)
2006/07
(n = 2,007)
Rank (%)
If my family doctor/nurse recommended it to me 1 (64) 1 (66) 1 (67) 1 (69) 1 (67) 1 (68)
If I had more information on the vaccine regarding 
efficacy and/or tolerance
– 2 (54) 2 (55) 2 (55) 2 (56) 2 (55)
If I knew more about the disease 2 (47) 3 (51) 3 (54) 3 (53) 3 (52) 3 (52)
If it were cheaper or reimbursed/free 4 (32) 4 (41) 4 (43) 4 (43) 4 (42) 4 (44)
If I could be vaccinated at work 3 (33) 5 (40) 5 (39) 6 (38) 5 (41) 5 (42)
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aged more than half of the surveyed, 
whereas a free or cheaper vaccine was 
mentioned by only two fifths. Of those 
responding in 2006/07, 45% intend to 
get vaccinated in the season 2007/08. 
The ratio of actual and intended vac-
cination rates remained in the range of 
0.6 over the years. Hence, there is a 
potential to increase vaccination cover-
age in Germany in the future. In order 
to achieve a vaccine uptake approach-
ing vaccination intention (44.7% in 
2007/08), activation of positive moti-
vations and dealing with barriers to 
vaccination remains an important task. 
This challenge should be taken up by 
the primary-care professionals, as they 
are the patients’ key motivators, and 
also by independent media, insurers, 
governments and health professionals’ 
organizations, which could all help 
bridging the knowledge gap.
CONCLUSION
The WHO considers the influenza 
pandemic risk to remain on a high lev-
el [3]. Efforts should be made at all 
national and international levels to in-
crease coverage according to the WHO 
objectives (i.e., 50% vaccination cover-
age to be reached in the elderly in 2006 
and 75% in 2010 [31]). Unlike in the 
year before, Germany fell short of 
meeting the goal as the 2006/07 vac-
cination rate reached only 45% in those 
aged ≥ 60 years, and 40% on average 
in all high-risk persons. Strong efforts 
need to be undertaken to reach the 
WHO objectives for 2010, a challenge 
to primary health-care providers, gov-
ernments, insurers, health organiza-
tions, and media.
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